This audio is automatically generated. Please let us know if you have any comments.
General contractor Mortenson broke ground on the third building of Serán Bioscience’s new 100,000-square-foot commercial manufacturing campus in Bend, Ore., according to a Jan. 8 ceremony.
The milestone marks the transition from structural construction to interior construction, according to the Minneapolis-based contractor. The third building, which is the centerpiece of the campus, will ultimately position the Bend area as a major center for advanced pharmaceutical development, according to a Mortenson press release sent to Construction Dive.
Serán Bioscience, a drug development company, did not officially disclose the total value of the project. But in a 2024 press release, the company said that The construction was supported by 200 million dollars strategic growth transaction with Bain Capital Life Sciences.
“The Serán project reflects the level of technical complexity and quality standards we see driving the growth of life sciences manufacturing today,” Pat Clemons, Mortenson’s project executive, said in the statement. “Our team is proud to support a facility designed specifically for advanced pharmaceutical production while contributing to the long-term economic strength of the Bend region.”
The campus, located near Serán’s 90,000-square-foot manufacturing and clinical development campus, will function as an extension of the company’s established clinical operations. The expansion follows Serán’s move last fall to complete two new warehouse and light manufacturing buildings, totaling about 50,000 square feet, according to the release.
Once completed, these spaces will support critical material handling, packaging, labeling and logistics functions.
“This is an important life sciences project for Central Oregon,” Mike Clifford, vice president and general manager of Mortenson, said in the statement. “By providing flexible, science-driven facilities, we are helping to translate innovation into commercially viable therapies while contributing to the continued growth of the region’s life sciences market.”
Mortenson expects the facility to begin operations in the second quarter of 2027, according to the release.
